Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
DocMorris AG banner

DocMorris AG
SIX:DOCM

Watchlist Manager
DocMorris AG Logo
DocMorris AG
SIX:DOCM
Watchlist
Price: 5.675 CHF 0.44%
Market Cap: CHf290.1m
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

DOCM Price Targets Summary
DocMorris AG

Wall Street analysts forecast DOCM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DOCM is 9.52 CHF with a low forecast of 5.05 CHF and a high forecast of 18.096 CHF.

DOCM Lowest Forecast
Wall Street Target
5.05 CHF
-11% Downside
DOCM Average Forecast
Wall Street Target
9.52 CHF
68% Upside
DOCM Highest Forecast
Wall Street Target
18.096 CHF
219% Upside
Lowest
Price Target
5.05 CHF
11% Downside
Average
Price Target
9.52 CHF
68% Upside
Highest
Price Target
18.096 CHF
219% Upside
DocMorris AG Competitors:
Price Targets
B
BEYOND
Bound and Beyond PCL
60% Upside
TB
Triboo SpA
30% Upside
ARTO
Bank Jago Tbk PT
55% Upside
B
BEYOND
Bound and Beyond PCL
60% Upside
TB
Triboo SpA
30% Upside
ARTO
Bank Jago Tbk PT
55% Upside

Revenue
Forecast

1% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
1% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

For the last 11 years the compound annual growth rate for DocMorris AG's revenue is 1%. The projected CAGR for the next 4 years is 16%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
11%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
11%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-51%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-51%
Average Miss

What are analyst estimates?

See Also

Summary
DOCM intrinsic value, competitors valuation, and company profile.
DCF Valuation
DOCM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DOCM stock valuation using valuation multiples.
Wall Street Estimates
DOCM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DOCM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DOCM's stock price target?
Price Target
9.52 CHF

According to Wall Street analysts, the average 1-year price target for DOCM is 9.52 CHF with a low forecast of 5.05 CHF and a high forecast of 18.096 CHF.

What is DocMorris AG's Revenue forecast?
Projected CAGR
16%

For the last 11 years the compound annual growth rate for DocMorris AG's revenue is 1%. The projected CAGR for the next 4 years is 16%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 316,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.